On Target Labs Drug Patent Portfolio
On Target Labs owns 1 orange book drug protected by 6 US patents Given below is the list of On Target Labs's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9254341 | Methods of manufacture of pteroyl-amino acid-fluorescent dyes | 04 Oct, 2033 | Active |
| US10881747 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | 26 Aug, 2033 | Active |
| US9061057 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | 26 Aug, 2033 | Active |
| US9333270 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | 26 Aug, 2033 | Active |
| US9341629 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | 26 Aug, 2033 | Active |
| US9789208 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | 26 Aug, 2033 | Active |
Latest Legal Activities on On Target Labs's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of On Target Labs.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 26 Jun, 2024 | US10881747 |
| transaction for FDA Determination of Regulatory Review Period | 27 Dec, 2023 | US9061057 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US9061057 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 20 Oct, 2023 | US9341629 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 17 Oct, 2023 | US9333270 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 28 Jul, 2023 | US9254341 |
| Second letter to regulating agency to determine regulatory review period | 25 Jan, 2023 | US9061057 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 07 Dec, 2022 | US9061057 |
| Letter from FDA or Dept of Agriculture re PTE application | 21 Sep, 2022 | US9061057 |
| Initial letter Re: PTE Application to regulating agency | 24 Feb, 2022 | US9061057 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 19 Jan, 2022 | US9061057 |
|
Email Notification
Critical
| 19 Jan, 2022 | US9061057 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 06 Apr, 2021 | US9789208 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Jan, 2021 | US10881747 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Jan, 2021 | US10881747 |
On Target Labs's Family Patents
On Target Labs drugs have patent protection in a total of 12 countries. It's US patent count contributes only to 36.4% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
On Target Labs Drug List
Given below is the complete list of On Target Labs's drugs and the patents protecting them.
1. Cytalux
Cytalux is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9254341 | Methods of manufacture of pteroyl-amino acid-fluorescent dyes |
04 Oct, 2033
(8 years from now)
| Active |
| US10881747 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors |
26 Aug, 2033
(8 years from now)
| Active |
| US9061057 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors |
26 Aug, 2033
(8 years from now)
| Active |
| US9333270 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors |
26 Aug, 2033
(8 years from now)
| Active |
| US9341629 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors |
26 Aug, 2033
(8 years from now)
| Active |
| US9789208 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors |
26 Aug, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cytalux's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List